The NICE recommendation for drug-coated balloons and its global impact

Conclusions: DCB angioplasty ought to be the preferred treatment option for patients with BMS-ISR and DES-ISR from the payers’ point of view.
Source: Therapeutic Advances in Cardiovascular Disease - Category: Cardiology Authors: Tags: Reviews Source Type: research